Sonothrombolysis in Patients With STEMI

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 15, 2017

Primary Completion Date

October 3, 2019

Study Completion Date

October 3, 2019

Conditions
ST-segment Elevation Myocardial Infarction
Interventions
DRUG

Definity, (Lipid Microspheres) Intravenous Suspension

Sonothrombolysis (High Impulse therapeutic ultrasound with infusion of ultrasound contrast agent Definity) will be applied before and after standard of care reperfusion therapy with PPCI

DEVICE

Myocardial Contrast Echocardiography

Myocardial contrast echocardiography will be applied before standard of care reperfusion therapy as well as prior to discharge and at 3 month follow up

PROCEDURE

Repurfusion therapy with PPCI

Patients will receive reperfusion therapy with PPCI as standard of care

Trial Locations (1)

Unknown

Mazankowski Alberta Heart Institute, Edmonton

All Listed Sponsors
collaborator

Alberta Health services

OTHER

collaborator

University of Alberta

OTHER

lead

Harald Becher

OTHER

NCT03092089 - Sonothrombolysis in Patients With STEMI | Biotech Hunter | Biotech Hunter